Amy Stewart

Dr. Maia Kayal is an Associate Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein IBD Center. She graduated from New York University School of Medicine Alpha Omega Alpha. She then completed her internal medicine residency at Columbia University Medical Center-New York Presbyterian Hospital and fellowship training in gastroenterology at the Mount Sinai Hospital. Dr. Kayal's research in inflammatory conditions of the ileal pouch is funded by the NIH, Crohn’s and Colitis Foundation, and Rainin Foundation. She is a former ACG Young Physicians Leadership Scholar and AGA Future Leader.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Dr. Shadi Hamdeh is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Kansas Medical Center. He earned his medical degree from Damascus University School of Medicine and completed his residency training in Internal Medicine at Creighton University Medical Center in Omaha, Nebraska. He subsequently completed fellowship training in Gastroenterology and Hepatology at the University of Kansas Medical Center. He pursued additional advanced fellowship training in Inflammatory Bowel Disease (IBD) at Northwestern University in Chicago.

Dr. Hamdeh’s clinical and academic interests focus on Inflammatory Bowel Diseases, particularly the development, evaluation, and clinical application of emerging therapies. He also has a strong academic interest in drug-induced gastrointestinal toxicity and has authored comprehensive review articles on drug-induced colitis and enteritis that have been widely cited and serve as important references in the field.

Dr. Hamdeh currently serves on the American College of Gastroenterology (ACG) FDA-Related Matters Committee and is a member of the Inflammatory Bowel Disease Committee of the World Gastroenterology Organisation (WGO). He also contributes to the academic community as a peer reviewer for multiple high-impact journals in gastroenterology.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Dr. Maia Kayal is an Associate Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein IBD Center. She graduated from New York University School of Medicine Alpha Omega Alpha. She then completed her internal medicine residency at Columbia University Medical Center-New York Presbyterian Hospital and fellowship training in gastroenterology at the Mount Sinai Hospital. Dr. Kayal's research in inflammatory conditions of the ileal pouch is funded by the NIH, Crohn’s and Colitis Foundation, and Rainin Foundation. She is a former ACG Young Physicians Leadership Scholar and AGA Future Leader.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Heather Rosario, PA-C, MHSc is an Inflammatory Bowel Disease Physician Assistant at Mercy Medical Center’s Melissa L Posner Center for Digestive Health and Liver Disease in Baltmiore, MD. She graduated from The Pennsylvania State University with degrees in Supply Chain & information Systems and Integrative arts and subsequently completed her Physician Assistant degree, at Pennsylvania College of Technology, and Masters in Health Science through Nova Southeastern University. Before falling in love with gastroenterology, she worked as a hospitalist, urgent care provider and primary care provider in a medically underserved area.

After working in a hybrid (inpatient and community) gastroenterology practice, she joined the Melissa L Posner Institute for Digestive Health and Liver Disease at Mercy Medical Center in Baltimore, MD, where she serves predominantly patients with inflammatory bowel disease. Additionally, she is responsible for development and implementation of EMR projects for the IBD team as well as leading the anal pap program. She has particular interest in optimizing care through patient education, provider education, and correcting healthcare disparities.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.

Dr. Shadi Hamdeh is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Kansas Medical Center. He earned his medical degree from Damascus University School of Medicine and completed his residency training in Internal Medicine at Creighton University Medical Center in Omaha, Nebraska. He subsequently completed fellowship training in Gastroenterology and Hepatology at the University of Kansas Medical Center. He pursued additional advanced fellowship training in Inflammatory Bowel Disease (IBD) at Northwestern University in Chicago.

Dr. Hamdeh’s clinical and academic interests focus on Inflammatory Bowel Diseases, particularly the development, evaluation, and clinical application of emerging therapies. He also has a strong academic interest in drug-induced gastrointestinal toxicity and has authored comprehensive review articles on drug-induced colitis and enteritis that have been widely cited and serve as important references in the field.

Dr. Hamdeh currently serves on the American College of Gastroenterology (ACG) FDA-Related Matters Committee and is a member of the Inflammatory Bowel Disease Committee of the World Gastroenterology Organisation (WGO). He also contributes to the academic community as a peer reviewer for multiple high-impact journals in gastroenterology.

Amy Stewart, MSN, FNP-C is the lead Advanced Practice Provider for her division of Capital Digestive Care in Washington, DC. In 2024, Amy was awarded the American College of Gastroenterology (ACG) APP Outstanding Research Award, Presidential Poster Award, and Outstanding Poster Presentation for an abstract on prior authorization and drug initiation times for IBD advanced therapies. She is the 2025 recipient of the State Award for Outstanding Contributions from the American Association of Nurse Practitioners for the District of Columbia. Amy is also the 2025 AGA-Pfizer Beacon of Hope award winner. She serves as the current vice-chair of the American College of Gastroenterology APP Committee, leads the new mentoring sub-committee, and is on the GHAPP (GI & Hepatology Advanced Practice Provider) Education Committee. Amy is passionate about APP education and excellent patient-centered care and speaks nationally and regionally.